These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26598601)

  • 1. p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells.
    Harajly M; Zalzali H; Nawaz Z; Ghayad SE; Ghamloush F; Basma H; Zainedin S; Rabeh W; Jabbour M; Tawil A; Badro DA; Evan GI; Saab R
    Mol Cell Biol; 2016 Feb; 36(3):438-51. PubMed ID: 26598601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
    Saab R; Rodriguez-Galindo C; Matmati K; Rehg JE; Baumer SH; Khoury JD; Billups C; Neale G; Helton KJ; Skapek SX
    Cancer Res; 2009 Jan; 69(2):440-8. PubMed ID: 19147556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutional t(16;22)(p13.3;q11.2 approximately 12) in a primitive neuroectodermal tumor of the pineal region.
    Sawyer JR; Sammartino G; Husain M; Linskey ME
    Cancer Genet Cytogenet; 2003 Apr; 142(1):73-6. PubMed ID: 12660038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
    Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
    Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
    Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
    Volk EL; Fan L; Schuster K; Rehg JE; Harris LC
    Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
    Hasegawa H; Yamada Y; Iha H; Tsukasaki K; Nagai K; Atogami S; Sugahara K; Tsuruda K; Ishizaki A; Kamihira S
    Leukemia; 2009 Nov; 23(11):2090-101. PubMed ID: 19710698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.
    Ta VB; de Bruijn MJ; ter Brugge PJ; van Hamburg JP; Diepstraten HJ; van Loo PF; Kersseboom R; Hendriks RW
    Blood; 2010 Feb; 115(7):1385-93. PubMed ID: 20008789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism.
    Polański R; Noon AP; Blaydes J; Phillips A; Rubbi CP; Parsons K; Vlatković N; Boyd MT
    Cancer Lett; 2014 Oct; 353(2):211-9. PubMed ID: 25067787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.
    Rigatti MJ; Verma R; Belinsky GS; Rosenberg DW; Giardina C
    Mol Carcinog; 2012 May; 51(5):363-78. PubMed ID: 21557332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bach1-mediated suppression of p53 is inhibited by p19(ARF) independently of MDM2.
    Nishizawa H; Ota K; Dohi Y; Ikura T; Igarashi K
    Cancer Sci; 2012 May; 103(5):897-903. PubMed ID: 22348305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling.
    Zhang C; Liu J; Wang X; Wu R; Lin M; Laddha SV; Yang Q; Chan CS; Feng Z
    Oncotarget; 2014 Oct; 5(19):9106-17. PubMed ID: 25193859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of p53 tumor suppressor gene in pineal parenchymal tumors.
    Tsumanuma I; Sato M; Okazaki H; Tanaka R; Washiyama K; Kawasaki T; Kumanishi T
    Noshuyo Byori; 1995 Mar; 12(1):39-43. PubMed ID: 7795728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy.
    Shchors K; Persson AI; Rostker F; Tihan T; Lyubynska N; Li N; Swigart LB; Berger MS; Hanahan D; Weiss WA; Evan GI
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1480-9. PubMed ID: 23542378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
    Künkele A; De Preter K; Heukamp L; Thor T; Pajtler KW; Hartmann W; Mittelbronn M; Grotzer MA; Deubzer HE; Speleman F; Schramm A; Eggert A; Schulte JH
    Neuro Oncol; 2012 Jul; 14(7):859-69. PubMed ID: 22591662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
    Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
    PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence.
    Xu X; Liu Q; Zhang C; Ren S; Xu L; Zhao Z; Dou H; Li P; Zhang X; Gong Y; Shao C
    Cell Death Dis; 2019 Mar; 10(4):282. PubMed ID: 30910997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.